无创高频振荡通气与NCPAP及NIPPV作为中国早产儿拔管后支持比较的随机临床试验
该多中心随机试验纳入1440例胎龄25周+0天至32周+6天准备拔管的早产儿,比较NHFOV、NCPAP和NIPPV三种拔管后无创通气策略。结果显示NHFOV较NIPPV和NCPAP略缩短有创机械通气时长,NHFOV和NIPPV再插管风险均低于NCPAP,三种技术安全性相当。
要点
- NHFOV较NIPPV和NCPAP略缩短有创机械通气时长。
- NHFOV和NIPPV再插管风险均低于NCPAP。
- 三种无创呼吸支持技术安全性相当。
核心结论
- 拔管后使用NHFOV至出院可略微缩短早产儿有创机械通气时长。
- NHFOV和NIPPV再插管风险均低于NCPAP。
- 三种呼吸支持技术在该人群中的安全性相当。
研究设计与样本
- 多中心、基于病理生理、评估者盲法、三组随机临床试验。
- 在中国69个三级转诊新生儿重症监护病房开展,招募时间为2017年12月1日至2021年5月31日。
- 纳入胎龄25周+0天至32周+6天、准备拔管的早产儿,随机接受NCPAP、NIPPV或NHFOV。
- 共纳入1440例新生儿,平均(SD)出生胎龄29.4(1.8)周,男婴860例(59.7%)。
- 按意向性治疗分析。
主要发现
- 与NHFOV相比,NCPAP组有创机械通气时长更长(均差1.5天;95%CI 0.3-2.7天;P=0.01)。
- NCPAP组无呼吸机天数少于NIPPV组(中位数[第25-75百分位]差-3[-6至-1]天;P=0.01)。
关键数值与推荐
- 主要结局为有创机械通气总时长、再插管需求和无呼吸机天数。
- 研究干预时长NHFOV组短于NIPPV组(中位数[第25-75百分位]差-1[-3至0]天;P=0.01)。
临床怎么用
- 对于胎龄25周+0天至32周+6天准备拔管的早产儿,可考虑拔管后使用NHFOV或NIPPV以降低再插管风险。
- NHFOV在缩短有创机械通气时长方面略优于NCPAP和NIPPV,但差异幅度较小。
- 三种无创呼吸支持技术安全性相当,临床选择可综合可用性与个体情况。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Several respiratory support techniques are available to minimize the use of invasive mechanical ventilation (IMV) in preterm neonates. It is unknown whether noninvasive high-frequency oscillatory ventilation (NHFOV) is more efficacious than nasal continuous positive airway pressure (NCPAP) or nasal intermittent positive pressure ventilation (NIPPV) in preterm neonates after their first extubation. OBJECTIVE: To test the hypothesis that NHFOV is more efficacious than NCPAP or NIPPV in reducing IMV after extubation and until neonatal intensive care unit discharge among preterm neonates. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, pathophysiology-based, assessor-blinded, 3-group, randomized clinical trial was conducted in 69 tertiary referral neonatal intensive care units in China, recruiting participants from December 1, 2017, to May 31, 2021. Preterm neonates who were between the gestational age of 25 weeks plus 0 days and 32 weeks plus 6 days and were ready to be extubated were randomized to receive NCPAP, NIPPV or NHFOV. Data were analyzed on an intention-to-treat basis. INTERVENTIONS: The NCPAP, NIPPV, or NHFOV treatment was initiated after the first extubation and lasted until discharge. MAIN OUTCOMES AND MEASURES: Primary outcomes were total duration of IMV, need for reintubation, and ventilator-free days. These outcomes were chosen to describe the effect of noninvasive ventilation strategy on the general need for IMV. RESULTS: A total of 1440 neonates (mean [SD] age at birth, 29.4 [1.8] weeks; 860 boys [59.7%]) were included in the trial. Duration of IMV was longer in NIPPV (mean difference, 1.2; 95% CI, 0.01-2.3 days; P = .04) and NCPAP (mean difference, 1.5 days; 95% CI, 0.3-2.7 days; P = .01) compared with NHFOV. Neonates who were treated with NCPAP needed reintubations more often than those who were treated with NIPPV (risk difference: 8.1%; 95% CI, 2.9%-13.3%; P = .003) and NHFOV (risk difference, 12.5%; 95% CI, 7.5%-17.4%; P < .001). There were fewer ventilator-free days in neonates treated with NCPAP than in those treated with NIPPV (median [25th-75th percentile] difference, -3 [-6 to -1] days; P = .01). There were no differences between secondary efficacy or safety outcomes, except for the use of postnatal corticosteroids (lower in NHFOV than in NCPAP group; risk difference, 7.3%; 95% CI, 2.6%-12%; P = .002), weekly weight gain (higher in NHFOV than in NCPAP group; mean difference, -0.9 g/d; 95% CI, -1.8 to 0 g/d; P = .04), and duration of study intervention (shorter in NHFOV than in NIPPV group; median [25th-75th percentile] difference, -1 [-3 to 0] days; P = .01). CONCLUSIONS AND RELEVANCE: Results of this trial indicated that NHFOV, if used after extubation and until discharge, slightly reduced the duration of IMV in preterm neonates, and both NHFOV and NIPPV resulted in a lower risk of reintubation than NCPAP. All 3 respiratory support techniques were equally safe for this patient population. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03181958.
引用
- Zhu X, Qi H, Feng Z, et al. Noninvasive High-Frequency Oscillatory Ventilation vs Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation as Postextubation Support for Preterm Neonates in China: A Randomized Clinical Trial. JAMA Pediatr. 2022. PMID: 35467744. doi:10.1001/jamapediatrics.2022.0710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。